Navigation Links
American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
Date:1/7/2008

NEW YORK, Jan. 7 /PRNewswire/ -- The American Stock Exchange LLC(R) (Amex(R)) announced today its final determination to remove the common stock (the "Securities") of Samaritan Pharmaceuticals, Inc. from listing on the Exchange, and filed an application on Form 25 to strike the Securities from listing with the Securities and Exchange Commission (the "SEC"). The delisting will become effective on January 17, 2008 unless postponed by the SEC.

Pursuant to its rules, the Exchange provided notice to Samaritan Pharmaceuticals, Inc. of the decision to delist the Securities and an opportunity to appeal the decision to a panel designated by the Exchange's Board of Governors.

In addition to this press release, the Exchange will provide public notice of its determination on its website. Notice will remain posted on the website until the delisting is effective.

About The American Stock Exchange

The American Stock Exchange(R) (Amex(R)) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 381 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com.


'/>"/>
SOURCE American Stock Exchange
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...age that,s too big or too heavy can lead to strain...Day News) -- There may be nothing wrong with stuff...t want to do the same thing with your suitcase as ...people were treated in 2008 in U.S. hospital emerg...dical facilities for luggage-related injuries, suc...
(Date:11/26/2009)... Benton Communications announ... growth system for retailers struggling to make an...WEB) November 26, 2009 -- Flu fears is the type of... the emergency room, according to Dr. David Benton...eleased business growth system – The Rfacto...
(Date:11/25/2009)..., TORONTOandCALGARY,Nov.25/PRNewswire/-Sentinell...ceImaging(MRI)coilsandsoftwareandCalgaryScientific...s,haveintroducedawebversionofAegis(TM)Breast4DAdva...erfaceisthefirsttrulyzero-footprintWebclientbasedm...,sPureWeb(TM)platformallowsforzero-footprintaccess...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAir... Winter Spare the Air Alert forThurs...edfirelogsoranyothersolidfuel,bothindoorsandoutdoo...thyairqualitytomorrow,"saidJackBroadbent,executive...tstorespectthehealthoftheirneighborsandfellowcommu...
(Date:11/25/2009)...es stress increase blood pressure? This simple qu...many years. New Stress-related gene Modulates Hig...ase blood pressure? This simple question has been...w new research has for the first time established ...ood pressure response to stress in mice as well as...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...nanostructure developed by researchers at the Univ...n promise in cancer therapy studies and could be u...applications as well. , The hollow gold nanosphe...rrow, and tunable absorption of light. Zhang is co...
...n safe from harmful rays , , SATURDAY, Mar...ther and more outdoor time for most Americans, and...n from the sun. , Before heading out, suggests the... indoors during these times is the best protection...
... Flax Council of Canada announced that a panel of ...milled flax seed be given Generally Recognized As ...a letter of "no objection", finalizing GRAS status...ide. , , Increasingly, to be accepted in the mass...
...ing, March 17, 2009, the first of two effective da...action Standards Final Rule goes into effect. Thi... (ASC) X12 Version 5010 replacing Version 4010A1 a...andards is mandatory by January 1, 2012. A new tr...
...uantum Group, Inc. (NYSE Amex: QGP ) ( www.Quant...notice on March 17, 2009 from the NYSE Amex (forme...fying the Company that it is not in compliance wit...ion to its overall operations or its existing fina...
...d may be driving the trend, doctors say , ...und the United States are reporting a sharp increa...e economy soured last year, with one noting that m...n because of the expense involved, and an increase...
Other Medicine News:Health News:Hollow gold nanospheres show promise for biomedical and other applications 2Health News:Hollow gold nanospheres show promise for biomedical and other applications 3Health News:With Spring Here, Use Sun Sense to Enjoy It 2Health News:Flax Council of Canada Announces GRAS Status Determined for Flax in U.S. 2Health News:Flax Council of Canada Announces GRAS Status Determined for Flax in U.S. 3Health News:Edifecs Announces New Version of Its Integrated HIPAA 5010 and ICD-10 Analysis and Migration Solution 2Health News:Edifecs Announces New Version of Its Integrated HIPAA 5010 and ICD-10 Analysis and Migration Solution 3Health News:The Quantum Group Receives a NYSE Amex Notification of a Listing Deficiency 2Health News:The Quantum Group Receives a NYSE Amex Notification of a Listing Deficiency 3Health News:The Quantum Group Receives a NYSE Amex Notification of a Listing Deficiency 4Health News:The Quantum Group Receives a NYSE Amex Notification of a Listing Deficiency 5Health News:With the Economy Down, Vasectomy Rates Are Up 2
(Date:11/25/2009)...RNewswire-FirstCall/--Hologic,Inc.(HologicortheCom...randsupplierofpremiumdiagnostics,medicalimagingsys...careneedsofwomen,isusingtheannualmeetingoftheRadio...inChicago,November29throughDecember3,2009tohighlig...mammographyworkstationsoftware. ,, TheHologicSe...
(Date:11/25/2009)...Newswire-FirstCall/--ERT(Nasdaq: ERES ),announcedt...andCEO,andKeithSchneck,theCompany,sExecutiveVicePr...PiperJaffrayHealthCareConferenceat1:30PMESTonDecem...rtiesmayaccessthepresentationbyvisitingtheCompany,...mayalsobeaccessedat http://www.corporate-ir.net/ir...
(Date:11/25/2009)...swire/--BioTrendsResearchGroup,Inc.releasedWave1of...inamulti-phasesyndicatedmarketresearchprojecttrack...roductlaunchthroughthefirstsixmonthsofavailability...nfrom75uniqueDermatologistsandqualitativeinformati...lara,obstaclestouse,typicalpatienttypes,productper...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Kevin Niksarli M D Of Newsight Laser Center New York N Y Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6 17 2009 49538 1Kevin Niksarli M D Of Newsight Laser Center New York N Y Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6 17 2009 49538 2Data 3A Actual imaging use far below presidents recommended 95 percent utilization rate for Medicare 49535 1Data 3A Actual imaging use far below presidents recommended 95 percent utilization rate for Medicare 49535 2Data 3A Actual imaging use far below presidents recommended 95 percent utilization rate for Medicare 49535 3Data 3A Actual imaging use far below presidents recommended 95 percent utilization rate for Medicare 49535 4DNC Chairman Tim Kaine Congratulates House Democrats on Progress of Health Care Reform Legislation 49532 1
...(Nasdaq and MTA: CTIC) announced today that extend...momab tiuxetan) First-line Indolent (FIT) study,pr...) 50th Annual Meeting by,Morschhauser, et al demon...ree,survival (PFS) following Zevalin consolidation...odgkin,s lymphoma who achieved a response to first...
...ar,atrial fibrillation receiving either 30 mg or 6...l oral Factor Xa inhibitor, experienced comparable...warfarin, according to new,Phase II data presented...Society of Hematology in San Francisco. These fin...al study evaluating an oral Factor Xa inhibitor in...
Other Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 2New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 3New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 4New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 5
VICTOR2 with fluorescence, fluorescence polarization and luminescence technologes
VICTOR2 with fluorescence and luminescence technologies, stackers and robotic loading system
Modular VICTOR2 multilabel counter with TR-fluorometry
...-channel parallel detection of fluorescence, absor...icrotiter plates. Compact workstations and system...port of microtiter plates with a throughput of > 1...itching required by numerous other systems to star...
Medicine Products: